Evoke Pharma Reports Third Quarter 2016 Results Read more about Evoke Pharma Reports Third Quarter 2016 Results
Evoke Pharma Schedules Webcast and Conference Call for Third Quarter 2016 Financial Results Read more about Evoke Pharma Schedules Webcast and Conference Call for Third Quarter 2016 Financial Results
Evoke Pharma Announces Positive Non-Clinical Pre-NDA Meeting with FDA for Gimoti Read more about Evoke Pharma Announces Positive Non-Clinical Pre-NDA Meeting with FDA for Gimoti
Evoke Pharma to Present at Rodman & Renshaw 18th Annual Global Investment Conference Read more about Evoke Pharma to Present at Rodman & Renshaw 18th Annual Global Investment Conference
Evoke Pharma Reports Second Quarter 2016 Results Read more about Evoke Pharma Reports Second Quarter 2016 Results
Evoke Pharma Schedules Webcast and Conference Call for Second Quarter 2016 Financial Results Read more about Evoke Pharma Schedules Webcast and Conference Call for Second Quarter 2016 Financial Results
Evoke Pharma Completes Credit Facility Repayment Read more about Evoke Pharma Completes Credit Facility Repayment
Evoke Pharma Announces $10 Million Registered Direct Offering Priced At-The-Market Read more about Evoke Pharma Announces $10 Million Registered Direct Offering Priced At-The-Market
Evoke Pharma Receives Conditional FDA Acceptance of Proposed Brand Name for EVK-001 Read more about Evoke Pharma Receives Conditional FDA Acceptance of Proposed Brand Name for EVK-001
Evoke Pharma Announces $4.5 Million At-The-Market Offering Read more about Evoke Pharma Announces $4.5 Million At-The-Market Offering